Evariant Ranked 239th Fastest Growing Company in North America on Deloitte’s 2016 Technology Fast 500™

Attributes 303 Percent Revenue Growth to the Healthcare Industry’s Need For a Comprehensive Healthcare CRM Platform to Increase Patient and Consumer Engagement

FARMINGTON, Conn.--()--Evariant, the leading provider of a healthcare CRM platform designed to help health systems transform the healthcare experience for their consumers, patients, and physicians today announced it ranked number 239 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America. Evariant grew 303 percent during this period.

“It is an honor to be recognized in Deloitte’s Technology Fast 500 for the second consecutive year,” said Bill Moschella, chief executive officer of Evariant. “As the healthcare industry continues to transform, customer relationship management (CRM) platforms are essential in helping hospitals and health systems better understand consumers and patients. The continued growth of our company showcases our commitment to serving the healthcare industry by providing hospitals and health systems with solutions that will increase patient engagement, drive physician alignment and help them adapt and thrive in dynamic market conditions.”

Evariant previously ranked 272nd as a Technology Fast 500™ award winner for 2015.

Overall, 2016 Technology Fast 500™ companies achieved revenue growth ranging from 121 percent to 66,661 percent from 2012 to 2015, with median growth of 290 percent.

About Deloitte’s 2016 Technology Fast 500™
Deloitte’s Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and energy tech companies – both public and private – in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2012 to 2015.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Companies must have base-year operating revenues of at least $50,000 USD, and current-year operating revenues of at least $5 million USD. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

As used in this document, “Deloitte” means Deloitte LLP and its subsidiaries. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.

About Evariant
Evariant provides the leading healthcare CRM platform designed to help health systems transform the healthcare experience for their consumers, patients, and physicians. Built in partnership with Salesforce®, the Customer Success Platform and world's #1 CRM, our solutions foster richer consumer/patient engagement and tighter physician alignment. Evariant’s platform, powered by industry-leading data and analytics, enables health systems to effectively communicate care options that increase revenue and market share, while optimizing network utilization. Many of the top health systems have selected Evariant to thrive in today’s hyper-competitive and rapidly changing environment. For more information, please visit www.evariant.com.

Contacts

Racepoint Global
Megan Ostrower, 617-624-3221
Evariant@racepointglobal.com

Contacts

Racepoint Global
Megan Ostrower, 617-624-3221
Evariant@racepointglobal.com